Navigation Links
Registration Compulsory For Nursing Homes, Clinics – Says A New Proposed Law By Health Ministr

Government-run health centres, hospitals, nursing homes, Diagnostic centres will soon need to be registered and also adhere to the minimum standards specified by law –// according to a new draft ‘Clinical Establishment Bill’ that has been finalised by the Health Ministry and is being sent to the cabinet for approval.

The proposed law will apply to all recognised systems of medicines, be it Allopathy, Unani or Ayurvedic and the same parameters will apply to a hospital, be it 10 or 1,000-bed. They will be given two years to register – Said an official from Health Ministry.

Till now, there was no central law to regulate them or availability of authentic data on nursing homes, diagnostic centres or type of facilities/expertise offered was available. Earlier such laws were enacted by some state governments to deal with the issue, but weren’t implemented yet. For example, In, Bombay and Delhi Nursing Homes, the Act was passed in 1949 and 1953 but rules could not be framed to implement it.

'The ministry has been trying to enact a law to deal with the problem since 1996. However, it took some time to arrive at the final stage because there were many issues involved.' – says a senior health ministry official. He added that the registration would be made compulsory even if the establishment had registered under any other state law according to the proposed Act and that there would be a registering authority at the district, state and national levels to ensure all comply with the law.

He also added: 'Presently, there's no uniformity in standard and one can get different reports from different centres for the same pathological tests. We have to standardize this.' A national council will be constituted to verify, categorize, and standardize them. Non-compliance would attract penalty ranging from Rs.500 to Rs five lakh.

'"/>




Page: 1

Related medicine news :

1. Actor Anil Kapoor Supports Birth Registration Cause
2. Registrations in NHS Dental Register Falls Short of Expectations
3. COAG Gets It Mostly Right On National Registration
4. Testing For HIV/AIDS Compulsory For New Military Recruits
5. Compulsory testing for heavy metal content in herbal medicines
6. Opposition to Compulsory Fortification of Bread with Folic Acid
7. Compulsory Rural Stint for Doctors: Ramadoss
8. Pre-Marital HIV Testing To Be Made Compulsory In AP, India
9. Proposed Compulsory Treatment For Alcohol Addicts
10. Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt
11. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
Post Your Comments:
Other Medicine News:Health News:Prime Healthcare Services to Acquire Three Hospitals from Tenet Healthcare Corporation 2Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 2Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 3Health News:Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs 4Health News:More girls than boys benefit from breastfeeding, Hopkins Children's research shows 2Health News:More girls than boys benefit from breastfeeding, Hopkins Children's research shows 3Health News:Bunk beds pose dangers to kids and adults 2Health News:Bunk beds pose dangers to kids and adults 3Health News:Large study identifies most costly adverse events in children's hospitals 2Health News:First study to examine vitamin D insufficiency in pediatric patients with low bone density 2
Breaking Medicine Technology:Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 1Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 2Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 3Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 4Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 5Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 6Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 7Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 8Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 9Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 10Oncolytics Biotech 28R 29 Inc Announces 2009 Second Quarter Results 13264 11ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 1ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 2ULURU Inc to Present Altrazeal 28TM 29 Clinical Evidence at the American Podiatric Medical Association 28APMA 29 Annual Scientific Meeting in Toront 53161 3Regence Wins Awards for Consumer Appeal to Transform Health Care 53156 1Regence Wins Awards for Consumer Appeal to Transform Health Care 53156 2